SEC Form 4 Summary UTHR

UTHR CEO Martine A. Rothblatt Sells 9,500 Shares

United Therapeutics (UTHR) CEO Martine A. Rothblatt sold 9,500 shares for $5,627,991.42 in 12 transactions.

Transaction Value:
$5,627,991.42
Shares transacted:
9,500
Average price:
$592.42
Insider:

The Form 4 filing, a report of changes in an insider's stock ownership, was submitted on Nov. 16, 2026. The trades took place on Nov. 13, 2026. It lists Martine A. Rothblatt as chairperson and chief executive of United Therapeutics (UTHR).

Transaction details

Transaction
Date of Earliest Transaction2026-11-13
Date of Latest Transaction2026-11-13
Buy/Sellsell
Transaction Count12
Shares Transacted9,500
Price$592.42
Total Transaction Value$5,627,991.42
Insider
Ticker SymbolUTHR
CompanyUNITED THERAPEUTICS Corp
Insider NameROTHBLATT MARTINE A
Insider TitleChairperson & CEO
Sector - IndustryHealthcare - Drug Manufacturers - Specialty & Generic
Holdings
Total Shares Owned After Transaction324,443
Position Size Change2.84%
Filing
Filing Date2026-11-16
SEC LinkView filing

FAQ

What type of transaction is this?

These were share sales, reported under transaction code S. The filing lists 12 transactions by one insider.

What was the average price of the transaction?

The average sale price was $592.42 per share across the 12 transactions. Separate prices for each sale were not available.

How did this transaction affect the insider's holdings?

Martine A. Rothblatt sold 9,500 shares and reported owning 324,443 shares afterward. The shares sold made up 2.84% of the reported starting balance of 333,943 shares.

What's the total transaction value?

The 12 sales had a total reported value of $5,627,991.42.

Are there any special circumstances around this transaction?

The transaction information includes a reference to a Rule 10b5-1 trading plan. These plans set trading instructions in advance. The available details do not show whether the reference covers all 12 sales or only some. Footnote text was not available to confirm which trades it covered, when the plan was set up, or its terms.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.